Snowball logo
logo
ABCL_logo

AbCellera Biologics Inc

$3.45-$0.16  (4.43%)

Frequently asked questions

What sector does AbCellera Biologics Inc (ABCL) operate in?

AbCellera Biologics Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is AbCellera Biologics Inc (ABCL) current stock price?

As of the latest data, AbCellera Biologics Inc stock price is $3.45, with a previous close of $3.61. AbCellera Biologics Inc lost -$0.16 in the last trading session, representing a -4.43% loss.

What is AbCellera Biologics Inc (ABCL) current market capitalization?

AbCellera Biologics Inc market cap is approximately 1.03 billion.

What is AbCellera Biologics Inc (ABCL) Earnings Per Share (EPS)?

The trailing EPS is -$0.57, and the forward EPS is -$0.64.

What is AbCellera Biologics Inc (ABCL) EBITDA?

AbCellera Biologics Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -40.22 million.

Does AbCellera Biologics Inc (ABCL) pay dividends?

No. AbCellera Biologics Inc does not pay a dividend.

How did AbCellera Biologics Inc (ABCL) perform in its most recent earnings report?

In the last report (December 31, 2025), AbCellera Biologics Inc posted an EPS surprise of -35.71% and a revenue surprise of 41.4%.

When is AbCellera Biologics Inc (ABCL) next earnings report?

AbCellera Biologics Inc is expected to release its next earnings report on March 31, 2026.

What is AbCellera Biologics Inc (ABCL) beta (volatility) score?

AbCellera Biologics Inc has a beta of 0.843, meaning its volatility is roughly in line with the market.